To Evaluate the Phase III Clinical Trial of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis
Clinical trial NCT06552520 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06552520
- Sponsor
- Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-08
- Primary completion
- 2025-09-11
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.